151 related articles for article (PubMed ID: 15339808)
21. The six-helix bundle of human immunodeficiency virus Env controls pore formation and enlargement and is initiated at residues proximal to the hairpin turn.
Markosyan RM; Leung MY; Cohen FS
J Virol; 2009 Oct; 83(19):10048-57. PubMed ID: 19625396
[TBL] [Abstract][Full Text] [Related]
22. Evidence that the transition of HIV-1 gp41 into a six-helix bundle, not the bundle configuration, induces membrane fusion.
Melikyan GB; Markosyan RM; Hemmati H; Delmedico MK; Lambert DM; Cohen FS
J Cell Biol; 2000 Oct; 151(2):413-23. PubMed ID: 11038187
[TBL] [Abstract][Full Text] [Related]
23. Analysis of the subgroup A avian sarcoma and leukosis virus receptor: the 40-residue, cysteine-rich, low-density lipoprotein receptor repeat motif of Tva is sufficient to mediate viral entry.
Rong L; Bates P
J Virol; 1995 Aug; 69(8):4847-53. PubMed ID: 7609052
[TBL] [Abstract][Full Text] [Related]
24. Retroviral entry mediated by receptor priming and low pH triggering of an envelope glycoprotein.
Mothes W; Boerger AL; Narayan S; Cunningham JM; Young JA
Cell; 2000 Nov; 103(4):679-89. PubMed ID: 11106737
[TBL] [Abstract][Full Text] [Related]
25. Receptor binding and low pH coactivate oncogenic retrovirus envelope-mediated fusion.
Côté M; Zheng YM; Liu SL
J Virol; 2009 Nov; 83(22):11447-55. PubMed ID: 19726505
[TBL] [Abstract][Full Text] [Related]
26. Alpharetrovirus envelope-receptor interactions.
Barnard RJ; Young JA
Curr Top Microbiol Immunol; 2003; 281():107-36. PubMed ID: 12932076
[TBL] [Abstract][Full Text] [Related]
27. An antibody that blocks human T-cell leukemia virus type 1 six-helix-bundle formation in vitro identified by a novel assay for inhibitors of envelope function.
Mirsaliotis A; Nurkiyanova K; Lamb D; Kuo CS; Brighty DW
J Gen Virol; 2007 Feb; 88(Pt 2):660-669. PubMed ID: 17251585
[TBL] [Abstract][Full Text] [Related]
28. Fusion induced by a class II viral fusion protein, semliki forest virus E1, is dependent on the voltage of the target cell.
Markosyan RM; Kielian M; Cohen FS
J Virol; 2007 Oct; 81(20):11218-25. PubMed ID: 17686870
[TBL] [Abstract][Full Text] [Related]
29. Leash in the groove mechanism of membrane fusion.
Park HE; Gruenke JA; White JM
Nat Struct Biol; 2003 Dec; 10(12):1048-53. PubMed ID: 14595397
[TBL] [Abstract][Full Text] [Related]
30. Enzootic nasal tumor virus envelope requires a very acidic pH for fusion activation and infection.
Côté M; Kucharski TJ; Liu SL
J Virol; 2008 Sep; 82(18):9023-34. PubMed ID: 18632865
[TBL] [Abstract][Full Text] [Related]
31. Two different molecular defects in the Tva receptor gene explain the resistance of two tvar lines of chickens to infection by subgroup A avian sarcoma and leukosis viruses.
Elleder D; Melder DC; Trejbalova K; Svoboda J; Federspiel MJ
J Virol; 2004 Dec; 78(24):13489-500. PubMed ID: 15564460
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of murine leukemia virus envelope protein (env) processing by intracellular expression of the env N-terminal heptad repeat region.
Ou W; Silver J
J Virol; 2005 Apr; 79(8):4782-92. PubMed ID: 15795264
[TBL] [Abstract][Full Text] [Related]
33. Exploring the membrane fusion mechanism through force-induced disassembly of HIV-1 six-helix bundle.
Gao K; Zhang Y; Lou J
Biochem Biophys Res Commun; 2016 May; 473(4):1185-1190. PubMed ID: 27079239
[TBL] [Abstract][Full Text] [Related]
34. Single residues in the surface subunits of oncogenic sheep retrovirus envelopes distinguish receptor-mediated triggering for fusion at low pH and infection.
Côté M; Zheng YM; Albritton LM; Liu SL
Virology; 2011 Dec; 421(2):173-83. PubMed ID: 22018783
[TBL] [Abstract][Full Text] [Related]
35. Receptor-induced thiolate couples Env activation to retrovirus fusion and infection.
Smith JG; Cunningham JM
PLoS Pathog; 2007 Dec; 3(12):e198. PubMed ID: 18260686
[TBL] [Abstract][Full Text] [Related]
36. Critical role of leucine-valine change in distinct low pH requirements for membrane fusion between two related retrovirus envelopes.
Côté M; Zheng YM; Li K; Xiang SH; Albritton LM; Liu SL
J Biol Chem; 2012 Mar; 287(10):7640-51. PubMed ID: 22235118
[TBL] [Abstract][Full Text] [Related]
37. Imaging single retrovirus entry through alternative receptor isoforms and intermediates of virus-endosome fusion.
Jha NK; Latinovic O; Martin E; Novitskiy G; Marin M; Miyauchi K; Naughton J; Young JA; Melikyan GB
PLoS Pathog; 2011 Jan; 7(1):e1001260. PubMed ID: 21283788
[TBL] [Abstract][Full Text] [Related]
38. Studies of the "chain reversal regions" of the avian sarcoma/leukosis virus (ASLV) and ebolavirus fusion proteins: analogous residues are important, and a His residue unique to EnvA affects the pH dependence of ASLV entry.
Delos SE; La B; Gilmartin A; White JM
J Virol; 2010 Jun; 84(11):5687-94. PubMed ID: 20335266
[TBL] [Abstract][Full Text] [Related]
39. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
[TBL] [Abstract][Full Text] [Related]
40. The mature avian leukosis virus subgroup A envelope glycoprotein is metastable, and refolding induced by the synergistic effects of receptor binding and low pH is coupled to infection.
Smith JG; Mothes W; Blacklow SC; Cunningham JM
J Virol; 2004 Feb; 78(3):1403-10. PubMed ID: 14722295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
